PPARA and cardiovascular disorder: Fibrates are synthetic ligands of PPARα and are commonly used for treatment of metabolic disorders that display dyslipidemia, such as non‐alcoholic fatty liver disease (NAFLD), cardiovascular disease, and type 2 diabetes (Kondo et al, 2010; Elam et al, 2011).